MX9701163A - Guanidinas de acidos tiofenilalquenilcarboxilicos sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene. - Google Patents
Guanidinas de acidos tiofenilalquenilcarboxilicos sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.Info
- Publication number
- MX9701163A MX9701163A MX9701163A MX9701163A MX9701163A MX 9701163 A MX9701163 A MX 9701163A MX 9701163 A MX9701163 A MX 9701163A MX 9701163 A MX9701163 A MX 9701163A MX 9701163 A MX9701163 A MX 9701163A
- Authority
- MX
- Mexico
- Prior art keywords
- medicament
- well
- preparation
- acid guanidines
- diagnosis agent
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 150000002357 guanidines Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 208000028867 ischemia Diseases 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 206010061216 Infarction Diseases 0.000 abstract 1
- 230000003288 anthiarrhythmic effect Effects 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 230000006793 arrhythmia Effects 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 230000003293 cardioprotective effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000007574 infarction Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 230000035778 pathophysiological process Effects 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19605610.1 | 1996-02-15 | ||
| DE19605610A DE19605610A1 (de) | 1996-02-15 | 1996-02-15 | Substituierte Thiophenylalkenylcarbonsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MXPA97001163A MXPA97001163A (en) | 1997-08-01 |
| MX9701163A true MX9701163A (es) | 1997-08-30 |
Family
ID=7785491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9701163A MX9701163A (es) | 1996-02-15 | 1997-02-14 | Guanidinas de acidos tiofenilalquenilcarboxilicos sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene. |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5756535A (enExample) |
| EP (1) | EP0790245B1 (enExample) |
| JP (1) | JP4402747B2 (enExample) |
| KR (1) | KR970061887A (enExample) |
| AR (1) | AR005812A1 (enExample) |
| AT (1) | ATE202096T1 (enExample) |
| AU (1) | AU706554B2 (enExample) |
| BR (1) | BR9700990A (enExample) |
| CA (1) | CA2197628C (enExample) |
| CZ (1) | CZ45597A3 (enExample) |
| DE (2) | DE19605610A1 (enExample) |
| DK (1) | DK0790245T3 (enExample) |
| ES (1) | ES2158383T3 (enExample) |
| GR (1) | GR3036122T3 (enExample) |
| HR (1) | HRP970081B1 (enExample) |
| HU (1) | HUP9700437A3 (enExample) |
| ID (1) | ID15889A (enExample) |
| IL (1) | IL120214A (enExample) |
| MX (1) | MX9701163A (enExample) |
| NO (1) | NO315424B1 (enExample) |
| NZ (1) | NZ314230A (enExample) |
| PL (1) | PL318412A1 (enExample) |
| PT (1) | PT790245E (enExample) |
| RU (1) | RU2193033C2 (enExample) |
| SI (1) | SI0790245T1 (enExample) |
| SK (1) | SK282440B6 (enExample) |
| TR (1) | TR199700109A2 (enExample) |
| TW (1) | TW445261B (enExample) |
| ZA (1) | ZA971260B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19634229A1 (de) * | 1996-08-23 | 1998-02-26 | Basf Ag | Photostabile UV-A-Filter enthaltende kosmetische Zubereitungen |
| US6160134A (en) * | 1997-12-24 | 2000-12-12 | Bristol-Myers Squibb Co. | Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
| US6011059A (en) * | 1997-12-24 | 2000-01-04 | Bristol-Myers Squibb Company | Acyl guanidine sodium/proton exchange inhibitors and method |
| JP2002542291A (ja) | 1999-04-23 | 2002-12-10 | ブリストル−マイヤーズ スクイブ カンパニー | ジ環式アシルグアニジン・ナトリウム／プロトン交換抑制剤および方法 |
| CA2464358C (en) | 2001-10-19 | 2011-05-24 | Toyama Chemical Co., Ltd. | Alkyl ether derivatives or their salts |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2734904A (en) * | 1956-02-14 | Xcxnhxc-nh | ||
| US4544670A (en) * | 1982-08-24 | 1985-10-01 | William H. Rorer, Inc. | Method of treating coccidiosis with acyl guanidines |
| GB9012252D0 (en) * | 1990-06-01 | 1990-07-18 | Lilly Industries Ltd | Pharmaceutical compounds |
| TW415937B (en) * | 1994-01-25 | 2000-12-21 | Hoechst Ag | Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| DE4402057A1 (de) * | 1994-01-25 | 1995-08-03 | Hoechst Ag | Perfluoralkylgruppen tragende phenyl-substituierte Alkylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4412334A1 (de) * | 1994-04-11 | 1995-10-19 | Hoechst Ag | Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4421536A1 (de) * | 1994-06-20 | 1995-12-21 | Hoechst Ag | Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1996
- 1996-02-15 DE DE19605610A patent/DE19605610A1/de not_active Withdrawn
-
1997
- 1997-02-03 DE DE59703746T patent/DE59703746D1/de not_active Expired - Lifetime
- 1997-02-03 AT AT97101597T patent/ATE202096T1/de not_active IP Right Cessation
- 1997-02-03 SI SI9730146T patent/SI0790245T1/xx unknown
- 1997-02-03 DK DK97101597T patent/DK0790245T3/da active
- 1997-02-03 PT PT97101597T patent/PT790245E/pt unknown
- 1997-02-03 EP EP97101597A patent/EP0790245B1/de not_active Expired - Lifetime
- 1997-02-03 ES ES97101597T patent/ES2158383T3/es not_active Expired - Lifetime
- 1997-02-05 ID IDP970354A patent/ID15889A/id unknown
- 1997-02-10 PL PL97318412A patent/PL318412A1/xx unknown
- 1997-02-11 US US08/798,259 patent/US5756535A/en not_active Expired - Lifetime
- 1997-02-13 IL IL12021497A patent/IL120214A/xx not_active IP Right Cessation
- 1997-02-13 AU AU12659/97A patent/AU706554B2/en not_active Ceased
- 1997-02-13 CZ CZ97455A patent/CZ45597A3/cs unknown
- 1997-02-13 SK SK213-97A patent/SK282440B6/sk unknown
- 1997-02-13 HR HR970081A patent/HRP970081B1/xx not_active IP Right Cessation
- 1997-02-13 AR ARP970100577A patent/AR005812A1/es unknown
- 1997-02-13 NZ NZ314230A patent/NZ314230A/en unknown
- 1997-02-13 TW TW086101574A patent/TW445261B/zh active
- 1997-02-13 TR TR97/00109A patent/TR199700109A2/xx unknown
- 1997-02-13 HU HU9700437A patent/HUP9700437A3/hu unknown
- 1997-02-14 ZA ZA9701260A patent/ZA971260B/xx unknown
- 1997-02-14 MX MX9701163A patent/MX9701163A/es unknown
- 1997-02-14 RU RU97102136/04A patent/RU2193033C2/ru not_active IP Right Cessation
- 1997-02-14 BR BR9700990A patent/BR9700990A/pt active Search and Examination
- 1997-02-14 KR KR1019970004337A patent/KR970061887A/ko not_active Ceased
- 1997-02-14 CA CA002197628A patent/CA2197628C/en not_active Expired - Fee Related
- 1997-02-14 JP JP02949597A patent/JP4402747B2/ja not_active Expired - Fee Related
- 1997-02-14 NO NO19970697A patent/NO315424B1/no not_active IP Right Cessation
-
2001
- 2001-06-27 GR GR20010400975T patent/GR3036122T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2183972A1 (en) | Oxazolidinone derivatives and pharmaceutical compositions containing them | |
| YU24402A (sh) | 2'-supstituisani 1,1'-bifenil-2-karbonamidi, postupak za njihovu proizvodnju, njihova primena kao leka kao i farmaceutski preparati koji sadrže ta jedinjenja | |
| WO2004005286A3 (en) | Viral inhibitors | |
| YU42503A (sh) | Arilovani furan-1 tiofen-amidi-karbonske kiseline sa blokirajućim dejstvom kalijumovog kanala | |
| CA2322644A1 (en) | Pharmaceutical composition of topiramate | |
| CA2215013A1 (en) | N-substituted indol-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action | |
| HK129093A (en) | N-tert-butyl-decahydro-2(3-amino-2-hydroxy-4-phenyl-butyl)isoquinoline-3-carboxamide & asparaginyl derivatives thereof | |
| CA2244785A1 (en) | Pentafluorobenzenesulfonamides and analogs | |
| BR0108694A (pt) | Derivados de ácido malÈnico, processo para preparação dos mesmos, uso dos mesmos como inibidor de atividade do fator xa e composições farmacêuticas que contêm os mesmos | |
| KR950031059A (ko) | 골다공증 치료용 약제학적 조성물 | |
| MY128014A (en) | Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors | |
| WO1999043636A3 (en) | Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs | |
| MX9603300A (es) | Derivados de la 4-sulfonilbenzoilguanidina o la 4-sulfinilbenzoilguanidina. | |
| CA2206366A1 (en) | Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them | |
| MX9704094A (es) | Benzoil-guanidinas sustituidas en orto, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene. | |
| TW200407290A (en) | Pentafluorosulfanylbenzoylguanidines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them | |
| CA2220533A1 (en) | 3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them | |
| WO2000066550A8 (en) | New compounds | |
| AU5067696A (en) | Antiarrhythmic and cardioprotective substituted indenoylguanidines | |
| MX9605538A (es) | Benzoil-guanidinas sustituidas con sulfonilamino, procedimiento para su preparacion, su empleo como medicamento o para diagnostico, asi como el medicamento que las contiene. | |
| RU94040865A (ru) | Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью | |
| MX9701323A (es) | Benzoilguanidinas sustituidas en posicion orto, un procedimiento para su preparacion, utilizacion como medicamento o agente diagnostico, asi como medicamento que la contiene. | |
| CA2206362A1 (en) | Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them | |
| CA2337397A1 (en) | 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same | |
| AU9080398A (en) | Novel diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them |